January 17, 2026
Saudi Arabia First to Approve Anktiva for Advanced Lung and Bladder Cancer
Saudi Arabia has granted conditional approval for Anktiva, a new cancer therapy for advanced lung and bladder cancers. This makes it the first nation worldwide to approve the treatment for non-small cell lung cancer (NSCLC), offering hope to patients after standard therapies fail.